Author

Wei-Jie Xu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Advances in immunotherapy for gastrointestinal malignancies

Gastrointestinal malignancies remain leading causes of cancer mortality, yet their sensitivity to immunotherapy differs sharply across anatomical sites, histologies, molecular subtypes, and disease stages. Immune checkpoint blockade has established durable clinical benefit in microsatellite instability-high colorectal...

Bo Liu, Lei Wang, Yue-Han Ma et al. · Frontiers in Immunology · 0 citations

Clinical trial Open access Oct 2026

Efficacy and safety of ifupinostat in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm phase 2 study

Ifupinostat (BEBT-908) is a novel dual-targeted inhibitor of histone deacetylase (HDACs) and phosphatidylinositol 3-kinase alpha (PI3Kα). We evaluated the efficacy and safety of ifupinostat monotherapy in patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL) after at least 2 prior lines of sy...

Yuan-Kai Shi, Peng Liu, Yu-Fu Li et al. · Signal Transduction and Targ... · 0 citations